Yes. I mean, Q1 is always a little bit more difficult in the HIM business. But there's kind of a -- there's a tail of a number of things that were happening. We did see census down. So there is a byproduct impact to -- because our HIM business is predominantly coders, coding of medical records. So if medical procedures are down, the need for coders is going to go down. So census was down, but I don't really believe that's the only driver of the revenue dynamics within HIM. One of the other things that we saw in HIM that we haven't really seen in the past is we saw customers that had approved hires to start and then came back and basically canceled those starts. And we saw that much more pervasive across many customers than we've experienced in the past, and what the customers were telling us is they were reallocating costs into other areas because what's happening in the hospitals right now, and you see this through more M&A activity within the hospitals, is the hospitals are coming to the realization, because of the Affordable Care Act, what's going to happen is the percentage of people that they're going to have to be taking care of, they're going to be more at the Medicare or Medicaid rates, which were a lower-margin business for them, is much higher. So they're going through major cost realignment within the hospital systems, which is part of what's driving the M&A, because you have smaller hospitals joining together, so they can get some leverage. So that played into that business as well, and then really, the third piece or the third leg that's impacted us is we went through a realignment of that business last year, just because of a lot of the statutory and compliance dynamics within that business, that we've had to apply resources because of HIPAA, high tech and various other things that have come down on that business. And we had to address some of those costs, and some of those costs, caused us to have some turnover because of realignments. So we're confident we did the right things for the long term of the business, but we're seeing a little bit of that impact.
Mark S. Marcon - Robert W. Baird & Co. Incorporated, Research Division: I appreciate the color. I mean, based on what you just said with regards to the HIM, with the exception of the third element that you mentioned, it doesn't sound like the other 2 are going to changing anytime soon, particularly the impact with regards to Medicare and Medicaid impacting the hospitals and the merger wave over there.